No Data
Last night, china assets went "crazy."
Overnight, the nasdaq Golden Dragon china index rose over 8.5%, marking the best single-day performance since the end of September. Popular Chinese concept etfs surged collectively: the largest MCHI increased by 7.7%, the FXI, which tracks large Chinese companies in the Hong Kong stock market, rose over 8%, and the only major Chinese concept etf tracking the A-share market, ASHR, gained nearly 7%. The most insane increase came from the three times leveraged FTSE China, YINN, which soared 24% overnight and continued to rise over 2% after hours.
Kweichow Moutai USA Investor Exchange Conference held in New York.
① Kweichow Moutai held a meeting for USA investors on December 4th in New York, attended by party committee member Jiang Yan, who engaged with over ten international renowned institutional investors. ② During the meeting, Jiang Yan introduced the history, craftsmanship, environment, brand influence, and performance in the capital markets of Moutai, emphasizing the importance Moutai places on investor interests and its concept of sustainable development.
The senior executive of the industrial bank has been "confirmed", with the appointment qualifications of Secretary of the Board, Xia Weichun, approved.
Setting the stage at the beginning of the year.
3 listed insurance companies flex their muscles! The China Life, New China Life, and Ping An collectively distribute a mid-term dividend of 17.252 billion yuan, with the highest dividend yield reaching 15.2%.
① Ping An Insurance distributed cash dividends of 9.914 billion yuan, accounting for 13.29% of the mid-term attributable net income; ② New China Life Insurance distributed cash dividends of 1.685 billion yuan, accounting for 15.2% of the mid-term attributable net income; ③ New China Life Insurance distributed cash dividends of 5.653 billion yuan, accounting for 14.77% of the mid-term attributable net income.
"Going global" and "innovation" are the key words that cannot be bypassed. Sun Piaoyang from Jiangsu Hengrui Pharmaceuticals, Zhu Yi from Baheal Pharm and other top pharmaceutical industry leaders jointly discuss the next decade | Industry Observation
On November 14, 2024, the opening ceremony of the Insight Conference was held in Chengdu, where experts in the pharmaceutical industry, investors, and chairmen of top listed companies exchanged views on the challenges and opportunities facing the China meheco group. The two key themes of "going global" and "innovation" ran through the entire conference. Faced with the question of the future direction of innovative drugs in China, various enterprises also provided different answers.
kweichow moutai's mid-term dividend is 30 billion yuan. The earliest buyback can be initiated on the 28th of this month. | Quick announcement.
1. Kweichow Moutai plans to distribute a mid-term dividend of 23.882 yuan per share (including tax), with a total cash payment of 30 billion yuan, which meets expectations; 2. In the afternoon of the 27th of this month, Kweichow Moutai will convene a shareholder meeting to deliberate on the repurchase matters, and it is expected to smoothly obtain shareholder approval, meaning that the company can start the repurchase process as early as the next day; 3. Recently, several brokerages have lowered their expectations for Kweichow Moutai's performance growth in 2025, generally expecting around 10%-11%.